These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37336662)

  • 1. Adherence to vaccination guidelines of patients with complete splenectomy in Norway, 2008-2020.
    Orangzeb S; Watle SV; Caugant DA
    Vaccine; 2023 Jul; 41(31):4579-4585. PubMed ID: 37336662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine coverage for recommended vaccines among splenectomised patients in Apulia, South Italy: a retrospective cohort study.
    Bianchi FP; Stefanizzi P; Di Lorenzo A; Cuscianna E; Tafuri S; Germinario CA
    BMJ Open; 2023 Mar; 13(3):e069316. PubMed ID: 36990496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive bacterial diseases: national surveillance in Italy and vaccination coverage in the Local Health Agency 4 "Chiavarese", Liguria region (Italy).
    Trucchi C; Zoppi G
    J Prev Med Hyg; 2012 Jun; 53(2):120-4. PubMed ID: 23240174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing infections in children and adults with asplenia.
    Lee GM
    Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):328-335. PubMed ID: 33275684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination status and immune response to 13-valent pneumococcal conjugate vaccine in asplenic individuals.
    Nived P; Jørgensen CS; Settergren B
    Vaccine; 2015 Mar; 33(14):1688-94. PubMed ID: 25707692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey of vaccine coverage and antibiotic prophylaxis in splenectomised patients in Scotland.
    Kyaw MH; Holmes EM; Chalmers J; Jones IG; Campbell H
    J Clin Pathol; 2002 Jun; 55(6):472-4. PubMed ID: 12037033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenocity of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old.
    Hu JL; Tao H; Li JX; Dai WM; Song B; Sun JF; Liu P; Tang J; Liu WY; Wang SY; Zhu FC
    Hum Vaccin Immunother; 2015; 11(5):1120-8. PubMed ID: 25833163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization coverage among splenectomized patients: Results of an ad hoc survey in Puglia Region (South of Italy).
    Martino C; Gallone MS; Quarto M; Germinario C; Tafuri S
    Hum Vaccin Immunother; 2016 May; 12(5):1277-9. PubMed ID: 26890256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of invasive diseases: strategies to increase vaccination coverage in children and adolescents.
    Zoppi G; Trucchi C
    J Prev Med Hyg; 2012 Jun; 53(2):125-9. PubMed ID: 23240175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-administration of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine does not interfere with the immune response to antigens contained in infant vaccines routinely used in the United States.
    Marshall GS; Marchant CD; Blatter M; Friedland LR; Aris E; Miller JM
    Hum Vaccin; 2011 Feb; 7(2):258-64. PubMed ID: 21307655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake and timeliness of rotavirus vaccination in Norway: The first year post-introduction.
    Valcarcel Salamanca B; Hagerup-Jenssen ME; Flem E
    Vaccine; 2016 Sep; 34(39):4684-4689. PubMed ID: 27522178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Haemophilus influenzae type b and Neisseria meningitidis serogroup C (HibMenC) or serogroup C and Y-tetanus toxoid conjugate (and HibMenCY) vaccines are well-tolerated and immunogenic when administered according to the 2,3,4 months schedule with a fourth dose at 12-18 months of age.
    Habermehl P; Leroux-Roels G; Sänger R; Mächler G; Boutriau D
    Hum Vaccin; 2010 Aug; 6(8):640-51. PubMed ID: 20697200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine Impact on Long-term Trends in Invasive Bacterial Disease in New Zealand Children.
    Walls T; Cho V; Martin N; Williman J; Brunton C
    Pediatr Infect Dis J; 2018 Oct; 37(10):1041-1047. PubMed ID: 30222697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine.
    Borrow R; Andrews N; Findlow H; Waight P; Southern J; Crowley-Luke A; Stapley L; England A; Findlow J; Miller E
    Clin Vaccine Immunol; 2010 Jan; 17(1):154-9. PubMed ID: 19906895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway.
    Vestrheim DF; Løvoll O; Aaberge IS; Caugant DA; Høiby EA; Bakke H; Bergsaker MR
    Vaccine; 2008 Jun; 26(26):3277-81. PubMed ID: 18456376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
    Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Registry for Patients With Asplenia/Hyposplenism Reduces the Risk of Infections With Encapsulated Organisms.
    Arnott A; Jones P; Franklin LJ; Spelman D; Leder K; Cheng AC
    Clin Infect Dis; 2018 Aug; 67(4):557-561. PubMed ID: 29471470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
    Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
    Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustaining immunity after immunization against encapsulated bacteria.
    Blanchard-Rohner G; Pollard AJ
    Hum Vaccin; 2008; 4(4):309-12. PubMed ID: 18398302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody Persistence in Young Children 5 Years after Vaccination with a Combined Haemophilus influenzae Type b-Neisseria meningitidis Serogroup C Conjugate Vaccine Coadministered with Diphtheria-Tetanus-Acellular Pertussis-Based and Pneumococcal Conjugate Vaccines.
    Tejedor JC; Brzostek J; Konior R; Grunert D; Kolhe D; Baine Y; Van Der Wielen M
    Clin Vaccine Immunol; 2016 Jul; 23(7):555-63. PubMed ID: 27145999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.